Nevertheless, besides the reduced NMNAT2 levels found in AD brains, there is no evidence of the involvement of key molecules that govern Wallerian degeneration—such as necroptosis-associated proteins or SARM1—in the context of AD. Here, NMNAT2 is linked to Alzheimer disease.